Citations (228)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hunter C. Jonus, Rebecca E. Burnham, Andrew Ho, Adeiye A. Pilgrim, Jenny Shim, Christopher B. Doering, H. Trent Spencer & Kelly C. Goldsmith. (2022) Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials. OncoImmunology 11:1.
Read now
Read now
Jeong Woo Kim, Ji Hye Yang & Eun-Joo Kim. (2020) SIRT1 and AROS suppress doxorubicin-induced apoptosis via inhibition of GSK3β activity in neuroblastoma cells. Animal Cells and Systems 24:1, pages 53-59.
Read now
Read now
Nikolai Siebert, Maxi Zumpe, Leon von Lojewski, Sascha Troschke-Meurer, Madlen Marx & Holger N. Lode. (2020) Reduction of CD11b+ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18/CHO. OncoImmunology 9:1.
Read now
Read now
Zhiping Li & Huijun Chen. (2019) miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3072-3078.
Read now
Read now
Sascha Troschke-Meurer, Nikolai Siebert, Madlen Marx, Maxi Zumpe, Karoline Ehlert, Oliver Mutschlechner, Hans Loibner, Ruth Ladenstein & Holger N. Lode. (2019) Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. OncoImmunology 8:12.
Read now
Read now
Rachel Huey, Dan Rathbone, Paul McCarron & Susan Hawthorne. (2019) Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells. Journal of Drug Targeting 27:9, pages 959-970.
Read now
Read now
Diarmuid Coughlan, Matthew Gianferante, Charles F Lynch, Jennifer L Stevens & Linda C Harlan. (2017) Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States. Pediatric Hematology and Oncology 34:5, pages 320-330.
Read now
Read now
Articles from other publishers (221)
Witida Laopajon, Nuchjira Takheaw, Kamonporn Kotemul, Supansa Pata, Suradej Hongeng & Watchara Kasinrerk. (2023) Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy. Exploration of Targeted Anti-tumor Therapy 4:6, pages 1145-1156.
Crossref
Crossref
Yi Zhang, Wei-Ling Zhang, Dong-Sheng Huang, Yi-Zhuo Wang, Hui-Min Hu, Tian Zhi & Yan-Yan Mei. (2023) Prognostic factors for intermediate- or high-risk neuroblastomas in children in China. BMC Pediatrics 23:1.
Crossref
Crossref
Lauren Helms, Allison E. Guimera, Katherine A. Janeway & Kelly M. Bailey. (2023) Innovations in Cancer Treatment of Children. Pediatrics 152:6.
Crossref
Crossref
Christophe Le Clorennec, Divya Subramonian, Yuchen Huo & Peter E. Zage. (2023) UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis. Cell Death & Disease 14:11.
Crossref
Crossref
Natalie S. Potter, Alan McLean, Evan C. Bornowski, Thomas Hopkins, Jingyi Luo, John P. Wolfe, Wei Qian & Raoul Kopelman. (2023) Flexible Synthesis Scheme and Application of AuNP Surface-Conjugatable Metaiodobenzylguanidine Derivatives for Enhanced Cellular Internalization. ACS Materials Letters 5:11, pages 2971-2977.
Crossref
Crossref
Javier Oesterheld, William Ferguson, Jacqueline M. Kraveka, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Don Berry, Randal K. Wada, Michael S. Isakoff, Don E. Eslin, Valerie I. Brown, William Roberts, Peter Zage, Virginia L. Harrod, Deanna S. Mitchell, Derek Hanson & Giselle L. Saulnier Sholler. (2023) Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons. Journal of Clinical Oncology.
Crossref
Crossref
Paulina Behrendt, Michael Boettcher, Kira Tabea Zierke, Safiullah Najem, Holger Zapf, Konrad Reinshagen, Wilhelm Wößmann & Johannes Boettcher. (2023) Health-Related Quality of Life and Mental Health of Children with Embryonal Abdominal Tumors. Children 10:10, pages 1720.
Crossref
Crossref
Cynthia Meyer, Melissa McCoy, Lianbo Li, Bruce Posner & Kenneth D. Westover. (2023) LIMS-Kinase provides sensitive and generalizable label-free in vitro measurement of kinase activity using mass spectrometry. Cell Reports Physical Science 4:10, pages 101599.
Crossref
Crossref
Carolina Carraro, Marco Rabusin, Flora Maria Murru, Lydie Ammar, Egidio Barbi, Alessandro Amaddeo & Giorgio Cozzi. (2023) Neck stiffness and bone osteolytic lesion in a 3-years old child: a case report. Italian Journal of Pediatrics 49:1.
Crossref
Crossref
Jinhui Gao, Claire Fosbrook, Jane Gibson, Timothy J. Underwood, Juliet C. Gray & Zoë S. Walters. (2023) Review: Targeting EZH2 in neuroblastoma. Cancer Treatment Reviews 119, pages 102600.
Crossref
Crossref
M. Stoks, I. Vieco-Martí, I. Noguera, M. Sánchez-Sánchez, R. Burgos-Panadero, S. Navarro & R. Noguera. (2023) Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma. Computers in Biology and Medicine 164, pages 107364.
Crossref
Crossref
Diana Corallo, Marco Dalla Vecchia, Daria Lazic, Sabine Taschner-Mandl, Alessandra Biffi & Sanja Aveic. (2023) The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma. Biochemical Pharmacology 215, pages 115696.
Crossref
Crossref
Katalin Mangó, Ferenc Fekete, Ádám Ferenc Kiss, Réka Erdős, János Tibor Fekete, Tamás Bűdi, Edit Bruckner, Miklós Garami, Tamás Micsik & Katalin Monostory. (2023) Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma. Scientific Reports 13:1.
Crossref
Crossref
Ruimin Hu, Yan Zhang, Siying Liu, Pamela Lee, Chaohong Liu & Aiguo Liu. (2023) Prognostic prediction by 18F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis. Frontiers in Oncology 13.
Crossref
Crossref
Jiajian Hu, Fengju Song, Wenjuan Kang, Fantong Xia, Zi’an Song, Yangyang Wang, Jie Li & Qiang Zhao. (2023) Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma. Frontiers in Pharmacology 14.
Crossref
Crossref
Xiao-Hui Wang, Shu-Feng Zhang, Hai-Ying Wu, Jian Gao, Lin Wang, Xu-Hui Wang & Tian-Hui Gao. (2023) miRNA326-5p Targets DKC1 Gene to Regulate Apoptosis-Related Proteins and Intervene in the Development of Neuroblastoma. Analytical Cellular Pathology 2023, pages 1-12.
Crossref
Crossref
H. Soliman, K. El-Noueam, A. Ettaby, S. Fadel & A.M. Abougabal. (2023) Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard. Clinical Radiology 78:7, pages e535-e541.
Crossref
Crossref
Haoru Wang, Ting Li, Xin Chen, Jin Zhu, Mingye Xie, Li Zhang, Hao Ding, Jinjie Qin & Ling He. (2023) Correlations Between Preoperative Radiographic Vascular Involvement of Abdominal/Pelvic Neuroblastomas on Computed Tomography and Intraoperative Vascular Injuries: Experience From a Tertiary Children's Hospital. Academic Radiology 30:7, pages 1350-1357.
Crossref
Crossref
Sema Serter Kocoglu, Fatma Bahar Sunay & Pakize Nur Akkaya. (2023) Effects of Monensin and Rapamycin Combination Therapy on Tumor Growth and Apoptosis in a Xenograft Mouse Model of Neuroblastoma. Antibiotics 12:6, pages 995.
Crossref
Crossref
Jasmine Y. Lee, Hunter C. Jonus, Arhanti Sadanand, Gianna M. Branella, Victor Maximov, Suttipong Suttapitugsakul, Matthew J. Schniederjan, Jenny Shim, Andrew Ho, Kiran K. Parwani, Andrew Fedanov, Adeiye A. Pilgrim, Jordan A. Silva, Robert W. Schnepp, Christopher B. Doering, Ronghu Wu, H. Trent Spencer & Kelly C. Goldsmith. (2023) Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Reports Medicine 4:6, pages 101091.
Crossref
Crossref
Kai Zhu, Jingjing He, Tiantuo Chen, Xiyang Yu, Xiaorui He & Yilin Su. (2023) Retroperitoneal localized neuroblastoma in children: a comparison of enhanced recovery after surgery versus traditional care. Pediatric Surgery International 39:1.
Crossref
Crossref
Peter E. Zage, Yuchen Huo, Divya Subramonian, Christophe Le Clorennec, Pradipta Ghosh & Debashis Sahoo. (2023) Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network. Genes, Chromosomes and Cancer 62:6, pages 313-331.
Crossref
Crossref
Mingzhen Li, Xiaoying Duan, Di You & Linlin Liu. (2023) Construction of a novel clinical nomogram to predict cancer-specific survival in patients with primary malignant adrenal tumors: a large population-based retrospective study. Frontiers in Medicine 10.
Crossref
Crossref
Lian Zhao, Liting Shi, Shun-gen Huang, Tian-na Cai, Wan-liang Guo, Xin Gao & Jian Wang. (2023) Identification and validation of radiomic features from computed tomography for preoperative classification of neuroblastic tumors in children. BMC Pediatrics 23:1.
Crossref
Crossref
Zoriamin Rivera, Carlos Escutia, Mary Beth Madonna & Kajal H. Gupta. (2023) Biological Insight and Recent Advancement in the Treatment of Neuroblastoma. International Journal of Molecular Sciences 24:10, pages 8470.
Crossref
Crossref
Prasoon Agarwal, Aleksandra Glowacka, Loay Mahmoud, Wesam Bazzar, Lars-Gunnar Larsson & Mohammad Alzrigat. (2023) MYCN Amplification Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. International Journal of Molecular Sciences 24:9, pages 8141.
Crossref
Crossref
Maria A. Karalexi, Marina Servitzoglou, Vassilios Papadakis, Denis Kachanov, Maja Česen Mazič, Margaret Baka, Maria Moschovi, Maria Kourti, Sofia Polychronopoulou, Eftichia Stiakaki, Emmanuel Hatzipantelis, Helen Dana, Kalliopi Stefanaki, Astero Malama, Marios S. Themistocleous, Katerina Strantzia, Tatyana Shamanskaya, Panagiota Bouka, Paraskevi Panagopoulou, Maria Kantzanou, Evangelia Ntzani, Nick Dessypris & Eleni Th. Petridou. (2023) Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries. European Journal of Cancer Prevention 32:3, pages 254-263.
Crossref
Crossref
Ramin Nasehi, Ali T. Abdallah, Marcella Pantile, Carlo Zanon, Michael Vogt, Stephan Rütten, Horst Fischer & Sanja Aveic. (2023) 3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model. Materials Today Bio 19, pages 100596.
Crossref
Crossref
Yimao Zhang, Yuhan Yang, Gang Ning, Xin Wu, Gang Yang & Yuan Li. (2023) Contrast computed tomography-based radiomics is correlation with COG risk stratification of neuroblastoma. Abdominal Radiology 48:6, pages 2111-2121.
Crossref
Crossref
Joseph D Lynch & Patrick J Tomboc. (2023) Neuroblastoma Masquerading as a Septic Hip Infection in a Three-Year-Old. Cureus.
Crossref
Crossref
Shihan Zhang, Chiyi Jiang, Yan Su, Jingang Gui, Zhixia Yue, Binglin Jian, Sidou He & Xiaoli Ma. (2023) Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Cheng Cheng, Tian He, Kai Chen, Yuanxia Cai, Yaoyao Gu, Lijia Pan, Peiwen Duan, Yeming Wu & Zhixiang Wu. (2023) P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma. Molecular & Cellular Proteomics 22:3, pages 100504.
Crossref
Crossref
Xia Zhou, Xiaokang Wang, Nan Li, Yu Guo, Xiaolin Yang & Yuhe Lei. (2023) Therapy resistance in neuroblastoma: Mechanisms and reversal strategies. Frontiers in Pharmacology 14.
Crossref
Crossref
Xiaoyan Xu, Meiqi Liu, Yanmin Zhang, Jie Wang, Xi Lei, Juanli Wang, Yafei Zhou & Tao Wang. (2023) Case report: Catecholamine cardiomyopathy in children with neuroblastoma. Frontiers in Pediatrics 11.
Crossref
Crossref
Atul Mourya, Purva Pingle, Chanti Katta Babu, Harithasree Veerabomma, Vaskuri G.S. Sainaga Jyothi, Jurica Novak, Prateek Pathak, Maria Grishina, Amita Verma, Rahul Kumar, Pankaj Kumar Singh, Dharmendra Kumar Khatri, Shashi Bala Singh & Jitender Madan. (2023) Computational and experimental therapeutic efficacy analysis of andrographolide phospholipid complex self-assembled nanoparticles against Neuro2a cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:2, pages 130283.
Crossref
Crossref
Yingyi Qi, Mengdi Li, Fangyuan Zhao, Wenfan Xue, Wang Qiong & Jianghua Zhan. (2023) A nomogram for the preoperative estimation of neuroblastoma risk despite inadequate biopsy information. Pediatric Surgery International 39:1.
Crossref
Crossref
Hong-Li Li, Lu-Lu Dong, Min-Jie Jin, Qian-Yu Li, Xiao Wang, Mei-Qi Jia, Jian Song, Sai-Yang Zhang & Shuo Yuan. (2023) A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. Molecules 28:3, pages 1141.
Crossref
Crossref
Wei-Qiang Tan, Li Yuan, Xu Cao, Xiao-Yuan Wu, Yi-Qun Xing & Ming Ye. (2023) Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo. Cancer Biomarkers 36:1, pages 53-61.
Crossref
Crossref
Yuying Wu & Jun Zhang. (2023) Study on differentially expressed genes between stage M and stage MS neuroblastoma. Frontiers in Oncology 12.
Crossref
Crossref
Yu Zhou & Jing Gao. (2023) A Novel Online Nomogram Established with Five Features before Surgical Resection for Predicating Prognosis of Neuroblastoma Children: A Population-Based Study. Technology in Cancer Research & Treatment 22, pages 153303382211451.
Crossref
Crossref
Jing Wang, Wang Dai & Ming Zhang. (2022) GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway. Anti-Cancer Drugs 34:1, pages 57-72.
Crossref
Crossref
Hao Wang, Bozhong Shi, Xiaoyang Zhang, Ping Shen, Qiao He, Minzhi Yin, Yi Pan & Jing Ma. (2023) Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1. Pathology - Research and Practice 241, pages 154240.
Crossref
Crossref
Kevin R. Moore & Christopher Güttler. 2023. Diagnostic Imaging: Pädiatrische Neuroradiologie. Diagnostic Imaging: Pädiatrische Neuroradiologie
1222
1226
.
Jennifer Cabral, Erica I. Fernandez, Bonnie Toy & Rita Secola. (2022) Multidisciplinary Clinical Care in the Management of Patients Receiving Anti-GD2 Immunotherapy for High-Risk Neuroblastoma. Pediatric Drugs 25:1, pages 13-25.
Crossref
Crossref
Jaume Mora, Godfrey C. Chan, Daniel A. Morgenstern, Karsten Nysom, Melissa K. Bear, Karen Tornøe & Brian H. Kushner. (2022) Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events. Cancer Reports 6:1.
Crossref
Crossref
Hu Yang, Jun Yang, Hongqiang Bian & Xin Wang. (2022) A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients. Frontiers in Pediatrics 10.
Crossref
Crossref
Yan-Ling Chen, Xiao-Lu Li, Gen Li, Yan-Fang Tao, Ran Zhuo, Hai-Bo Cao, Wan-yan Jiao, Zhi-Heng Li, Zhen-Hong Zhu, Fang Fang, Yi Xie, Xin-Mei Liao, Di Wu, Hai-Rong Wang, Juan-Juan Yu, Si-Qi Jia, Yang Yang, Chen-Xi Feng, Peng-Cheng Yang, Xiao-Dong Fei, Jian-Wei Wang, Yun-Yun Xu, Guang-Hui Qian, Zi-Mu Zhang & Jian Pan. (2022) BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma. Cell & Bioscience 12:1.
Crossref
Crossref
Kai Gao, Congying Wu, Yanlong Li, Jian Lu & Yuwu Jiang. (2022) Transcriptome Analysis Reveals the Anti-Tumor Mechanism of Eucalyptol Treatment on Neuroblastoma Cell Line SH-SY5Y. Neurochemical Research 47:12, pages 3854-3862.
Crossref
Crossref
Yuta Takeuchi, Seiichiro Inoue & Akio Odaka. (2022) Expression of programmed cell death-1 on neuroblastoma cells in TH-MYCN transgenic mice. Pediatric Surgery International 39:1.
Crossref
Crossref
Carlo Caffarelli, Francesca Santamaria, Ettore Piro, Simona Basilicata, Valeria Delle Cave, Marilena Cipullo, Sergio Bernasconi & Giovanni Corsello. (2022) New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and telemedicine. Italian Journal of Pediatrics 48:1.
Crossref
Crossref
Balanescu Laura, Balanescu Radu, Cimpeanu Patricia & Moga Andreea. (2022) Association of Image-Defined Risk Factors with Clinical, Biological Features and Outcome in Neuroblastoma. Children 9:11, pages 1707.
Crossref
Crossref
Zhenjian Zhuo, Lei Lin, Lei Miao, Meng Li & Jing He. (2022) Advances in liquid biopsy in neuroblastoma. Fundamental Research 2:6, pages 903-917.
Crossref
Crossref
Roshna Lawrence Gomez, Shakhzada Ibragimova, Revathy Ramachandran, Anna Philpott & Fahad R. Ali. (2022) Tumoral heterogeneity in neuroblastoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:6, pages 188805.
Crossref
Crossref
Tingting Chen, Chenggong Zeng, Zhuoran Li, Juan Wang, Feifei Sun, Junting Huang, Suying Lu, Jia Zhu, Yizhuo Zhang, Xiaofei Sun & Zijun Zhen. (2022) Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma. Frontiers in Oncology 12.
Crossref
Crossref
Valerio Passudetti, Luca De Leo, Filippo Maselli, Raffaello Pellegrino & Fabrizio Brindisino. (2022) Tumour Hidden behind Thoracic Spine Pain: A Rare Case of Neuroblastoma in a Young Mother—A Case Report. International Journal of Environmental Research and Public Health 19:20, pages 13448.
Crossref
Crossref
Hua Wang, Xiaowen Zhou, Chenbei Li, Shuxiang Yan, Chengyao Feng, Jieyu He, Zhihong Li & Chao Tu. (2022) The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Jennifer T. Castle, Brittany E. Levy & David A. Rodeberg. (2022) Abdominal Tumors. Surgical Clinics of North America 102:5, pages 715-737.
Crossref
Crossref
Yongshu Li, Bihui Huang, Zhichao Xue, Yunhua Gao & Zhenjian Zhuo. (2022) Nucleic acid therapy in pediatric cancer. Pharmacological Research 184, pages 106441.
Crossref
Crossref
Xiao-Mao Tian, Bin Xiang, Yi-Hang Yu, Qi Li, Zhao-Xia Zhang, Chenghao Zhanghuang, Li-Ming Jin, Jin-Kui Wang, Tao Mi, Mei-Lin Chen, Feng Liu & Guang-Hui Wei. (2022) A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. Frontiers in Immunology 13.
Crossref
Crossref
Quan Sun, Yanmin Chen, Qianya Jin & Xiaojun Yuan. (2022) A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma. European Journal of Pediatrics 181:12, pages 4135-4147.
Crossref
Crossref
Chia-Lang Hsu, Chieh-Fan Yin, Yi-Wen Chang, Ya-Chih Fan, Shih-Han Lin, Yu-Ching Wu, Hsuan-Cheng Huang & Hsueh-Fen Juan. (2022) LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1/2. Cell Death & Disease 13:9.
Crossref
Crossref
Flávia Marcella Sena Gonçalves Borba, Andressa de Almeida, Emanuelle Scarlath Tomaz, Nágella Samara Eleutério da Silva & Cibelle Ferreira Louzada. (2022) Aspectos Clínicos e Fatores Prognósticos do Neuroblastoma: Relato de Caso. Revista Brasileira de Cancerologia 68:3.
Crossref
Crossref
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, Silvia Lampis, Andrea Pession, Patrizia Hrelia & Roberto Tonelli. (2022) MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment. Cancers 14:18, pages 4421.
Crossref
Crossref
Zemin Lv, Yunyun Yu, Yangmei Luo, Song Lin, Xuang Xiang, Xiaowen Mao & Shigang Cheng. (2022) Long-term survival outcomes of pediatric adrenal malignancies: An analysis with the upstaged SEER registry during 2000-2019. Frontiers in Endocrinology 13.
Crossref
Crossref
Cynthia M. LaFond, Alyssa Yost, Kelly Lankin, Megha Kilaru & Susan L. Cohn. (2022)
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for
131
I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study
. Journal of Pediatric Hematology/Oncology Nursing 39:5, pages 304-316.
Crossref
Crossref
Nanjing Liu, Chunmei Yang, Li Yang, Ting Li, Maoyuan Gong, Haobiao Wang, Jun Zhang, Hui Zhao, Lin Zou & Xiaoyan He. (2022) Matrine induces autophagy in human neuroblastoma cells via blocking the AKT-mTOR pathway. Medical Oncology 39:11.
Crossref
Crossref
Andrés Augusto González-Arboleda, Nicolás Fernandez & Herney Andrés García-Perdomo. (2022) Genitourinary Tract Tumors in Children: An Update. Current Pediatric Reviews 18:3, pages 166-178.
Crossref
Crossref
Qian Zhang, Jingli Wei, Na Li & Bailing Liu. (2022) LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1. Neurochemical Research 47:8, pages 2278-2293.
Crossref
Crossref
Quan Jin, Jianmu Li, Fan Yang, Lingling Feng & Xin Du. (2022) Circular RNA circKIF2A Contributes to the Progression of Neuroblastoma Through Regulating PRPS1 Expression by Sponging miR-377-3p. Biochemical Genetics 60:4, pages 1380-1401.
Crossref
Crossref
Fateme Salemi, Waqas Alam, Maryam Sadat Hassani, Seyedeh Zohreh Hashemi, Amirhossein Azari Jafari, Seyyed Mohammad Sadeq Mirmoeeni, Mona Arbab, Seyed Mohammad Reza Mortazavizadeh & Haroon Khan. (2022) Neuroblastoma: Essential genetic pathways and current therapeutic options. European Journal of Pharmacology 926, pages 175030.
Crossref
Crossref
Seongmoon Jo, Sang Hee Im, Dongryul Seo, Hayeon Ryu, Sung Hoon Kim, Dawoon Baek, Ahreum Baek & Sung-Rae Cho. (2022) Low-frequency repetitive magnetic stimulation suppresses neuroblastoma progression by downregulating the Wnt/β-catenin signaling pathway. Bioelectrochemistry, pages 108205.
Crossref
Crossref
Tanvir Ahmed. (2022) Immunotherapy for neuroblastoma using mRNA vaccines. Advances in Cancer Biology - Metastasis 4, pages 100033.
Crossref
Crossref
Hana Golan, Raphael Mechoulam, Reem Smoum, Efrat Cohen-Zada, Sara Pri-Chen, Sapir Wiener, Igor Grinberg, Dekel D. Bar-Lev, Christeeneh G. Haj, Tamar Fisher & Amos Toren. (2022) Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells. Biomedicines 10:7, pages 1552.
Crossref
Crossref
Vincent Montero, Marc Montana, Omar Khoumeri, Florian Correard, Marie-Anne Estève & Patrice Vanelle. (2022) Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives. Pharmaceuticals 15:7, pages 781.
Crossref
Crossref
Frederic A. Vallejo, Anthony Sanchez, Branko Cuglievan, Winston M. Walters, Guillermo De Angulo, Steven Vanni & Regina M. Graham. (2022) NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth. Frontiers in Oncology 12.
Crossref
Crossref
Hui Yan, Bo Zhai, Fang Yang, Zhenliang Chen, Qiang Zhou, Ana Cláudia Paiva-Santos, Ziqiao Yuan & Yang Zhou. (2022) Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Frontiers in Pharmacology 13.
Crossref
Crossref
Esmee C. M. Kooijmans, Helena J. H. van der Pal, Saskia M. F. Pluijm, Margriet van der Heiden-van der Loo, Leontien C. M. Kremer, Dorine Bresters, Eline van Dulmen-den Broeder, Marry M. van den Heuvel-Eibrink, Jacqueline J. Loonen, Marloes Louwerens, Sebastian J. C. Neggers, Cécile Ronckers, Wim J. E. Tissing, Andrica C. H. de Vries, Gertjan J. L. Kaspers, Arend Bökenkamp & Margreet A. Veening. (2022) Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study. Cancers 14:11, pages 2754.
Crossref
Crossref
Can Qi, Yun Zhou, Zhonghui Hu, Huizhong Niu, Fang Yue, Huibo An, Zhiguo Chen, Ping Wang, Le Wang & Guochen Duan. (2022) The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma. Journal of International Medical Research 50:6, pages 030006052211093.
Crossref
Crossref
Philip Deslarzes, Reza Djafarrian, Maurice Matter, Stefano La Rosa, Carole Gengler, Maja Beck-Popovic & Tobias Zingg. (2022) Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature. Frontiers in Pediatrics 10.
Crossref
Crossref
Wei-Qiang Tan, Li Yuan, Xiao-Yan Wu, Cheng-Guang He, Shai-Cheng Zhu & Ming Ye. (2022) Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma. Cancer Biomarkers 34:3, pages 375-384.
Crossref
Crossref
Cátia Granja & Lourdes Mota. (2022) Paediatric neuroblastoma presenting as an asymptomatic abdominal mass: a report on the importance of a complete clinical examination with a view to a timely diagnosis and therapeutic guidance in paediatric oncology. BMJ Case Reports 15:5, pages e247907.
Crossref
Crossref
Briana E. Heinly & Christa N. Grant. (2022) Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential. Frontiers in Oncology 12.
Crossref
Crossref
J. van Heerden, T.M. Esterhuizen, M. Hendricks, J. Poole, A. Büchner, G. Naidu, J. du Plessis, B. van Emmenes, A. van Zyl, E. Mathews & M. Kruger. (2022) The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa. Clinical Oncology 34:4, pages e149-e159.
Crossref
Crossref
Yongping Chen, Lei Miao, Huiran Lin, Zhenjian Zhuo & Jing He. (2022) The role of m6A modification in pediatric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:2, pages 188691.
Crossref
Crossref
U. Sh. Kuz’mina, G. Z. Raskil’dina, D. V. Ishmetova, G. N. Sakhabutdinova, Sh. Sh. Dzhumaev, Yu. G. Borisova, Yu. V. Vakhitova & S. S. Zlotskii. (2022) Cytotoxic Activity Against SH-SY5Y Neuroblastoma Cells of Heterocyclic Compounds Containing gem-Dichlorocyclopropane and/or 1,3-Dioxacycloalkane Fragments. Pharmaceutical Chemistry Journal 55:12, pages 1293-1298.
Crossref
Crossref
Brianna Spencer, Akshilkumar Patel, Robert Cilley & Christa N. Grant. (2021) Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience. World Journal of Pediatrics 18:2, pages 120-125.
Crossref
Crossref
Pedro Ozorio Brum, Guilherme Danielski Viola, Carolina Saibro-Girardi, Camila Tiefensee-Ribeiro, Matheus Ozorio Brum, Juciano Gasparotto, Rachel Krolow, José Cláudio Fonseca Moreira & Daniel Pens Gelain. (2021) Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation. Neurochemical Research 47:2, pages 409-421.
Crossref
Crossref
Chunyang Zhang, Zhaozheng Ding & Hong Luo. (2022) The Prognostic Role of m6A-Related Genes in Paediatric Neuroblastoma Patients. Computational and Mathematical Methods in Medicine 2022, pages 1-13.
Crossref
Crossref
Gonzalo Botella Casas, Marta de Lucio, Ana López Saiz & Miguel Puche Torres. (2022) Ganglioneuroblastoma cervical gigante como causa de trastornos del sueño en niños. Revista Española de Cirugía Oral y Maxilofacial 44.
Crossref
Crossref
荣 唐. (2022) Common Pediatric Tumors and There Surgical Nursing. Nursing Science 11:04, pages 470-476.
Crossref
Crossref
Franziska Cuntz, Hedwig E. Deubzer, Johannes H. Schulte, Antje Nimtz-Talaska, Angelika Eggert & Susanne Holzhauer. (2022) Hemostatic Management in an Infant With Neuroblastoma and Severe Hemophilia B With Extended Half-life Recombinant Factor IX Fusion Protein. Journal of Pediatric Hematology/Oncology 44:1, pages e246-e249.
Crossref
Crossref
Monika Achbergerová, Stanislava Hederová, Andrea Hrašková & Alexandra Kolenová. (2022) Dinutuximab beta in the treatment of high-risk neuroblastoma. Medicine 101:4, pages e28716.
Crossref
Crossref
Rameswari Chilamakuri, Danielle C. Rouse, Yang Yu, Abbas S. Kabir, Aaron Muth, Jianhua Yang, Jeffery M. Lipton & Saurabh Agarwal. (2022) BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy. Translational Oncology 15:1, pages 101272.
Crossref
Crossref
Elwin D. Clutter, Liaohai L. Chen & Rong R. Wang. (2022) Role of photobleaching process of indocyanine green for killing neuroblastoma cells. Biochemical and Biophysical Research Communications 589, pages 254-259.
Crossref
Crossref
Meryle J. Eklund, Tejal Mody, Adina L. Alazraki & Marilyn J. Siegel. 2022. Evidence-Based Imaging in Pediatrics. Evidence-Based Imaging in Pediatrics
1
18
.
Xiaodan Zhong, Songling Zhang, Yutong Zhang, Zongmiao Jiang, Yanan Li, Jian Chang, Junqi Niu & Ying Shi. (2021) HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Chi-yi Jiang, Xiao Xu, Bing-lin Jian, Xue Zhang, Zhi-xia Yue, Wei Guo & Xiao-li Ma. (2021) Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis. Italian Journal of Pediatrics 47:1.
Crossref
Crossref
Lijia Pan, Cheng Cheng, Peiwen Duan, Kai Chen, Yeming Wu & Zhixiang Wu. (2021) XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Jennifer C. Kasemeier-Kulesa, Jennifer A. Spengler, Connor E. Muolo, Jason A. Morrison, Thomas E. Woolley, Santiago Schnell & Paul M. Kulesa. (2021) The embryonic trunk neural crest microenvironment regulates the plasticity and invasion of human neuroblastoma via TrkB signaling. Developmental Biology 480, pages 78-90.
Crossref
Crossref
Bin Yamaoka, Eri Nagasaki-Maeoka, Shota Uekusa, Ayano Hidaka, Kohei Hijikata, Reona Kato, Kyoko Fujiwara, Tsugumichi Koshinaga & Shuichiro Uehara. (2021) Exosomal miR-214-3p as a potential novel biomarker for rhabdoid tumor of the kidney. Pediatric Surgery International 37:12, pages 1783-1790.
Crossref
Crossref
Francesca Musumeci, Annarita Cianciusi, Ilaria D’Agostino, Giancarlo Grossi, Anna Carbone & Silvia Schenone. (2021) Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma. Molecules 26:23, pages 7069.
Crossref
Crossref
Shibo Zhu, Xiangliang Tang, Xiaofeng Gao, Jingqi Zhang, Yanhong Cui, Dian Li & Wei Jia. (2021) hsa_circ_0013401 Accelerates the Growth and Metastasis and Prevents Apoptosis and Autophagy of Neuroblastoma Cells by Sponging miR-195 to Release PAK2. Oxidative Medicine and Cellular Longevity 2021, pages 1-21.
Crossref
Crossref
Valerio Voglino, Giorgio Persano, Alessandro Crocoli, Aurora Castellano, Annalisa Serra, Ugo Giordano, Gian Luigi Natali, Pier Luigi Di Paolo, Cristina Martucci, Alessandra Stracuzzi & Alessandro Inserra. (2021) Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients. Frontiers in Pediatrics 9.
Crossref
Crossref
Agnieszka Kaczmarska, Patrycja Śliwa, Monika Lejman & Joanna Zawitkowska. (2021) The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?. International Journal of Molecular Sciences 22:21, pages 12089.
Crossref
Crossref
Ying Liu, Liang Huo, Jinhua Zhang & Ying Liu. (2021) Intracranial Metastases Tend to Be Overt and Predict Poor Prognosis in Children With Neuroblastoma. Frontiers in Pediatrics 9.
Crossref
Crossref
Tharushi P. Wijesinghe, Mahendiran Dharmasivam, Charles C. Dai & Des R. Richardson. (2021) Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc. Pharmacological Research 173, pages 105889.
Crossref
Crossref
Xiao-Hui Wang, Shu-Feng Zhang, Hai-Ying Wu, Jian Gao, Xu-Hui Wang & Tian-Hui Gao. (2021) SOX17 inhibits proliferation and invasion of neuroblastoma through CXCL12/CXCR4 signaling axis. Cellular Signalling 87, pages 110093.
Crossref
Crossref
Giuseppe Barone, Ailish Barry, Francisco Bautista, Bénédicte Brichard, Anne-Sophie Defachelles, Fiona Herd, Carla Manzitti, Dirk Reinhardt, Pedro M. Rubio, Aleksandra Wieczorek & Max M. van Noesel. (2021) Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance. Pediatric Drugs 23:6, pages 537-548.
Crossref
Crossref
Etienne C. Gozlan, Boris I. Chobrutskiy, Saif Zaman, Michelle Yeagley & George Blanck. (2021) Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells. Journal of Molecular Neuroscience 71:11, pages 2393-2404.
Crossref
Crossref
Praveen Bhoopathi, Padmanabhan Mannangatti, Luni Emdad, Swadesh K. Das & Paul B. Fisher. (2021) The quest to develop an effective therapy for neuroblastoma. Journal of Cellular Physiology 236:11, pages 7775-7791.
Crossref
Crossref
Anna M. Wulf, Marcela M. Moreno, Chloé Paka, Alexandra Rampasekova & Karen J. Liu. (2021) Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer. International Journal of Molecular Sciences 22:21, pages 11718.
Crossref
Crossref
Wenjuan Kang, Jiajian Hu, Qiang Zhao & Fengju Song. (2021) Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yingyi Qi & Jianghua Zhan. (2021) Roles of Surgery in the Treatment of Patients With High-Risk Neuroblastoma in the Children Oncology Group Study: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics 9.
Crossref
Crossref
Elena Paccosi, Michele Costantino, Alessio Balzerano, Silvia Filippi, Stefano Brancorsini & Luca Proietti-De-Santis. (2021) Neuroblastoma Cells Depend on CSB for Faithful Execution of Cytokinesis and Survival. International Journal of Molecular Sciences 22:18, pages 10070.
Crossref
Crossref
Annette K. Brenner & Maria W. Gunnes. (2021) Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update. Pharmaceutics 13:9, pages 1427.
Crossref
Crossref
Zijie Ye, Danyang Chen, Ruilin Zheng, Haiyang Chen, Tiantian Xu, Changbing Wang, Shibo Zhu, Xiaofeng Gao, Jin Zhang, Dian Li, Yueyin Pang, Bing Zhu, Yinghua Li & Wei Jia. (2021) Curcumin induced G2/M cycle arrest in SK‐N‐SH neuroblastoma cells through the ROS‐mediated p53 signaling pathway. Journal of Food Biochemistry 45:9.
Crossref
Crossref
Chang Liu, Yasuyuki Gen, Kousuke Tanimoto, Tomoki Muramatsu, Jun Inoue & Johji Inazawa. (2021) Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular Therapy - Nucleic Acids 25, pages 83-92.
Crossref
Crossref
Giorgia Centonze, Jennifer Chapelle, Costanza Angelini, Dora Natalini, Davide Cangelosi, Vincenzo Salemme, Alessandro Morellato, Emilia Turco & Paola Defilippi. 2021. Pheochromocytoma, Paraganglioma and Neuroblastoma. Pheochromocytoma, Paraganglioma and Neuroblastoma.
Ruiqing Lu, Yinan Jiang, Xianxin Lai, Shujie Liu, Litao Sun & Zhong-Wei Zhou. (2021) A Shortage of FTH Induces ROS and Sensitizes RAS-Proficient Neuroblastoma N2A Cells to Ferroptosis. International Journal of Molecular Sciences 22:16, pages 8898.
Crossref
Crossref
Chunhua Bi, Jili Shan, Maoxiang Li, Qian Zhang, Caihua Li, Jianning Tong & Qikun Huang. (2021) Long noncoding RNA differentiation antagonizing nonprotein coding RNA promotes the proliferation, invasion and migration of neuroblastoma cells via targeting β-1, 4-galactosyltransferase III by sponging miR-338-3p. NeuroReport 32:12, pages 965-974.
Crossref
Crossref
Sarra El-Soussi, Reine Hanna, Hanna Semaan, Amanda-Rose Khater, Jad Abdallah, Wassim Abou-Kheir & Tamara Abou-Antoun. (2021) A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins. Frontiers in Pediatrics 9.
Crossref
Crossref
Hongxu Li, Jie Gao & Shuijun Zhang. (2021) Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Kween Saimuang, Khomson Suttisintong, Narongpol Kaewchangwat, Eknarin Thanayupong, Yodsathorn Wongngam, Putthiporn Charoenphun, Rujira Wanotayan, Abdelhamid Elaissari, Suradej Hongeng, Duangporn Polpanich & Kulachart Jangpatarapongsa. (2021)
A model of modified
meta
-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment
. RSC Advances 11:41, pages 25199-25206.
Crossref
Crossref
Yuichi Togashi, Tomoko Tanaka, Masakazu Takemoto, Yuki Takeuchi, Mayumi Higashi, Shigehisa Fumino & Tatsuro Tajiri. (2021) Anti-relapse effect of trametinib on a local minimal residual disease neuroblastoma mouse model. Journal of Pediatric Surgery 56:7, pages 1233-1239.
Crossref
Crossref
Hüseyin ABDİK. (2021) COMBINED EFFECTS OF ZOLEDRONIC ACID AND SODIUM PENTABORATE PENTAHYDRATE ON PROLIFERATION, MIGRATION AND APOPTOSIS OF HUMAN NEUROBLASTOMA CELL LINE. Middle East Journal of Science 7:1, pages 24-35.
Crossref
Crossref
Patrizia Garbati, Raffaella Barbieri, Matilde Calderoni, Francesca Baldini, Mario Nizzari, Paola Modesto, Tullio Florio & Aldo Pagano. (2021) Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice. International Journal of Molecular Sciences 22:13, pages 6753.
Crossref
Crossref
Irene Paraboschi, Ester Bolognesi, Adele Giannettoni, Stefano Avanzini, Michele Torre & Giuseppe Martucciello. (2021) The Role of Biopsy in the Workup of Patients with Neuroblastoma: Comparison of the Incidence of Surgical Complications and the Diagnostic Reliability of Diverse Techniques. Children 8:6, pages 500.
Crossref
Crossref
Bin He, Jianshui Mao & Leyi Huang. (2021) Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Jaques van Heerden, Natasha Abraham, Judy Schoeman, David Reynders, Elvira Singh & Mariana Kruger. (2021) Reporting Incidences of Neuroblastoma in Various Resource Settings. JCO Global Oncology:7, pages 947-964.
Crossref
Crossref
Yiheng Yang, Hongli Pan, Jie Chen, Zhonghua Zhang, Minna Liang & Xunqiang Feng. (2021) CircKIF2A contributes to cell proliferation, migration, invasion and glycolysis in human neuroblastoma by regulating miR-129-5p/PLK4 axis. Molecular and Cellular Biochemistry 476:6, pages 2513-2525.
Crossref
Crossref
Andrea Pelosi, Piera Filomena Fiore, Sabina Di Matteo, Irene Veneziani, Ignazio Caruana, Stefan Ebert, Enrico Munari, Lorenzo Moretta, Enrico Maggi & Bruno Azzarone. (2021) Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors. Cancers 13:10, pages 2374.
Crossref
Crossref
Jeremy Han, Jordan Hastings, Monica Phimmachanh, Dirk Fey, Walter Kolch & David Croucher. (2021) Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response. Journal of Personalized Medicine 11:5, pages 395.
Crossref
Crossref
Danny Misiak, Sven Hagemann, Jessica L. Bell, Bianca Busch, Marcell Lederer, Nadine Bley, Johannes H. Schulte & Stefan Hüttelmaier. (2021) The MicroRNA Landscape of MYCN-Amplified Neuroblastoma. Frontiers in Oncology 11.
Crossref
Crossref
Paula Martinez Sanz, Dieke J van Rees, Lieke M J van Zogchel, Bart Klein, Panagiota Bouti, Hugo Olsman, Karin Schornagel, Ivana Kok, Ali Sunak, Kira Leeuwenburg, Ilse Timmerman, Miranda P Dierselhuis, Waleed M Kholosy, Jan J Molenaar, Robin van Bruggen, Timo K van den Berg, Taco W Kuijpers, Hanke L Matlung, Godelieve A M Tytgat & Katka Franke. (2021) G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment. Journal for ImmunoTherapy of Cancer 9:5, pages e002259.
Crossref
Crossref
Natale Belluardo, Giuseppa Mudò, Valentina Di Liberto, Monica Frinchi, Daniele F. Condorelli, Ugo Traversa, Francisco Ciruela, Renata Ciccarelli, Patrizia Di Iorio & Patricia Giuliani. (2021) Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms. Frontiers in Pharmacology 12.
Crossref
Crossref
Katharina Körholz, Johannes Ridinger, Damir Krunic, Sara Najafi, Xenia F. Gerloff, Karen Frese, Benjamin Meder, Heike Peterziel, Silvia Vega-Rubin-de-Celis, Olaf Witt & Ina Oehme. (2021) Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma. Cells 10:5, pages 1001.
Crossref
Crossref
Junichi Hara, Chika Nitani, Hiroshi Kawamoto, Tomoaki Taguchi, Toshimi Kimura, Kenichi Yoshimura & Kiyoshi Yoshimura. (2021) A Phase I/IIa Study of Antidisialoganglioside Antibody Dinutuximab in Japanese Patients With Neuroblastoma. Journal of Pediatric Hematology/Oncology 43:3, pages e358-e364.
Crossref
Crossref
Kai Zhu, Liang Wang, Xiao Zhang, Hua Sun, Tiantuo Chen, Chuancheng Sun, Feng Zhang, Yufei Zhu, Xiyang Yu, Xiaorui He & Yilin Su. (2021) LncRNA HCP5 promotes neuroblastoma proliferation by regulating miR-186-5p/MAP3K2 signal axis. Journal of Pediatric Surgery 56:4, pages 778-787.
Crossref
Crossref
Ming Chen, Meng Zhao, Yan Hou & Bin Zhu. (2021) Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth. Molecular and Cellular Biochemistry 476:4, pages 1871-1879.
Crossref
Crossref
Jaques van Heerden, Tonya Esterhuizen & Mariana Kruger. (2021) Inequity in paediatric oncology in South Africa – The neuroblastoma case study. South African Journal of Oncology 5.
Crossref
Crossref
Christina Skofler, Florian Kleinegger, Stefanie Krassnig, Anna Maria Birkl-Toeglhofer, Georg Singer, Holger Till, Martin Benesch, Regina Cencic, John A. PorcoJr.Jr., Jerry Pelletier, Christoph Castellani, Andrea Raicht, Ewa Izycka-Swieszewska, Piotr Czapiewski & Johannes Haybaeck. (2021) Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma. Cells 10:2, pages 301.
Crossref
Crossref
María Victoria Ruiz-Pérez, Lourdes Sainero-Alcolado, Ganna Oliynyk, Isabell Matuschek, Nicola Balboni, S.J. Kumari A. Ubhayasekera, Marteinn Thor Snaebjornsson, Kamil Makowski, Kristina Aaltonen, Daniel Bexell, Dolors Serra, Roland Nilsson, Jonas Bergquist, Almut Schulze & Marie Arsenian-Henriksson. (2021) Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. iScience 24:2, pages 102128.
Crossref
Crossref
Reine Hanna, Jad Abdallah & Tamara Abou-Antoun. (2021) A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells. Frontiers in Oncology 10.
Crossref
Crossref
Jun Liu, Mingyu Zhang, Ying Kan, Wei Wang, Jie Liu, Jianhua Gong & Jigang Yang. (2021) Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Sébastien Benzekry, Coline Sentis, Carole Coze, Laëtitia Tessonnier & Nicolas André. (2021) Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis. JCO Clinical Cancer Informatics:5, pages 81-90.
Crossref
Crossref
Li-Jia Pan, Jian-Lei Chen, Zhi-Xiang Wu & Ye-Ming Wu. (2021) Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma. Technology in Cancer Research & Treatment 20, pages 153303382110391.
Crossref
Crossref
Jixue Zhao, Liyu Yao, Shu Nie & Yang Xu. (2021) Low-viscosity sodium alginate combined with TiO2 nanoparticles for improving neuroblastoma treatment. International Journal of Biological Macromolecules 167, pages 921-933.
Crossref
Crossref
Sin Wi Ng, Yinghan Chan, Xin Yi Ng, Kamal Dua & Dinesh Kumar Chellappan. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
281
297
.
Svetlana Kvint, Zarina S. Ali, Line G. Jacques, Gregory Heuer & Eric L. Zager. 2021. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors
273
299
.
Roger P. Harrie, Ariana M. Levin & Leah Owen. (2021) Recurrent Subconjunctival Hemorrhage in a Child With an Orbital Mass. JAMA Ophthalmology 139:1, pages 125.
Crossref
Crossref
Piamsiri Sawaisorn, Korakot Atjanasuppat, Usanarat Anurathapan, Somchai Chutipongtanate & Suradej Hongeng. (2020) Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma. Vaccines 8:4, pages 753.
Crossref
Crossref
Yirong Ge, Sihai Tan, Jing Bi, Mei Rao, Yuli Yu & Lidan Tian. (2020) SNHG16 knockdown inhibits tumorigenicity of neuroblastoma in children via miR-15b-5p/PRPS1 axis. NeuroReport 31:17, pages 1225-1235.
Crossref
Crossref
Yan Su, Lijun Wang, Chiyi Jiang, Zhixia Yue, Hongjun Fan, Huimin Hong, Chao Duan, Mei Jin, Dawei Zhang, Lihua Qiu, Xianfeng Cheng, Zhong Xu & Xiaoli Ma. (2020) Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma. BMC Cancer 20:1.
Crossref
Crossref
Illya Martynov, Jessica Klima-Frysch & Joachim Schoenberger. (2020) A scientometric analysis of neuroblastoma research. BMC Cancer 20:1.
Crossref
Crossref
Zegao Jin, Yang Lu, Yizhe Wu, Jinxin Che & Xiaowu Dong. (2020) Development of differentiation modulators and targeted agents for treating neuroblastoma. European Journal of Medicinal Chemistry 207, pages 112818.
Crossref
Crossref
Ozge Balpinar Nalci, Hayrunnisa Nadaroglu, Sidika Genc, Ahmet Hacimuftuoglu & Azize Alayli. (2020) The effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell line. Molecular Biology Reports 47:12, pages 9715-9723.
Crossref
Crossref
Anna Maria Lucianò, Elisa Perciballi, Mario Fiore, Donatella Del Bufalo & Ada Maria Tata. (2020) The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells. International Journal of Molecular Sciences 21:22, pages 8433.
Crossref
Crossref
Jing Zhang, Yuanyuan Zhao, Jianhua Wang, Tal Sneh, Qianqian Yu, Xiao Zhou & Chen Gong. (2020) NBPF1 independently determine the risk stratification and prognosis of patients with neuroblastoma. Genomics 112:6, pages 3951-3957.
Crossref
Crossref
Yan Su, Lijun Wang, Qian Zhao, Zhixia Yue, Wen Zhao, Xisi Wang, Chao Duan, Mei Jin, Dawei Zhang, Shenglan Chen, Jianfeng Yin, Lihua Qiu, Xianfeng Cheng, Zhong Xu & Xiaoli Ma. (2020)
Implementation of the plasma
MYCN
/
NAGK
ratio to detect
MYCN
amplification in patients with neuroblastoma
. Molecular Oncology 14:11, pages 2884-2893.
Crossref
Crossref
Tiene Bauters, Veronique Van de Velde, Stefanie Bekaert & Geneviève Laureys. (2020) Optimizing care for high-risk neuroblastoma patients treated with dinutuximab: Challenges for the multidisciplinary team. Journal of Oncology Pharmacy Practice 26:7, pages 1721-1724.
Crossref
Crossref
Joyobrato Nath, Rajib Paul, Sankar Kumar Ghosh, Jaishree Paul, Baby Singha & Nitu Debnath. (2020) Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 258, pages 118189.
Crossref
Crossref
Venugopal Gunda, Anup S. Pathania, Srinivas Chava, Philip Prathipati, Nagendra K. Chaturvedi, Don W. Coulter, Manoj K. Pandey, Donald L. Durden & Kishore B. Challagundla. (2020) Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma. Cancers 12:9, pages 2576.
Crossref
Crossref
Yan Su, Hong Qin, Chenghao Chen, Shengcai Wang, Shihan Zhang, Dawei Zhang, Mei Jin, Yun Peng, Lejian He, Xiaoman Wang, Suyun Qian, Maoquan Qin, Ming Ge, Fuquan Zhang, Qi Zeng, Huanmin Wang, Xiaoli Ma & Xin Ni. (2020) Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China. Pediatric Investigation 4:3, pages 157-167.
Crossref
Crossref
Jaques van Heerden & Mariana Kruger. (2020) Management of neuroblastoma in limited-resource settings. World Journal of Clinical Oncology 11:8, pages 629-643.
Crossref
Crossref
Divya Subramonian, Nikki Phanhthilath, Hannah Rinehardt, Sean Flynn, Yuchen Huo, Jing Zhang, Karen Messer, Qianxing Mo, Shixia Huang, Jacqueline Lesperance & Peter E. Zage. (2020) Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways. British Journal of Cancer 123:4, pages 568-579.
Crossref
Crossref
Angela Duvalyan, Angela Cha, Fariba Goodarzian, Alexandre Arkader, Judith G. Villablanca & Araz Marachelian. (2020) Premature epiphyseal growth plate arrest after isotretinoin therapy for high‐risk neuroblastoma: A case series and review of the literature. Pediatric Blood & Cancer 67:8.
Crossref
Crossref
Sonia Simon Serrano, Wondossen Sime, Yasmin Abassi, Renée Daams, Ramin Massoumi & Mohamed Jemaà. (2020) Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma. Scientific Reports 10:1.
Crossref
Crossref
Zhichao Wang, Huiyan Cheng, Huali Xu, Xiaofeng Yu & Dayun Sui. (2020) A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma. Cancer Biomarkers 28:3, pages 275-284.
Crossref
Crossref
Danny R Youlden, Brendan C Jones, Thomas P Cundy, Jonathan Karpelowsky, Joanne F Aitken & Craig A McBride. (2020) Incidence and outcomes of neuroblastoma in Australian children: A population‐based study (1983–2015). Journal of Paediatrics and Child Health 56:7, pages 1046-1052.
Crossref
Crossref
Karin Toews, Laura Grunewald, Silke Schwiebert, Anika Klaus, Annika Winkler, Solin Ali, Felix Zirngibl, Kathy Astrahantseff, Dimitrios L. Wagner, Anton G. Henssen, Hedwig E. Deubzer, Johannes H. Schulte, Sebastian Ochsenreither, Angelika Eggert & Annette Künkele. (2020) Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells. Molecular Carcinogenesis 59:7, pages 724-735.
Crossref
Crossref
Jordan S. Taylor, Burcin Yavuz, Jasmine Zeki, Lauren Wood, Naohiko Ikegaki, Jeannine Coburn, Kristin Harrington, Hiroyuki Shimada, David L. Kaplan & Bill Chiu. (2020) Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma. Surgery 167:6, pages 969-977.
Crossref
Crossref
Defeng Deng, Shuangjie Yang & Xiang Wang. (2020) Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells. Bioscience Reports 40:5.
Crossref
Crossref
Kevin Adam, Jacqueline Lesperance, Tony Hunter & Peter E. Zage. (2020) The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. International Journal of Molecular Sciences 21:9, pages 3319.
Crossref
Crossref
Mattie J. Casey & Rodney A. Stewart. (2020) Pediatric Cancer Models in Zebrafish. Trends in Cancer 6:5, pages 407-418.
Crossref
Crossref
C. Rodríguez-Nogales, S. Mura, P. Couvreur & M.J. Blanco-Prieto. (2020) Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice. International Journal of Pharmaceutics 582, pages 119345.
Crossref
Crossref
Qin Zhao, Yang Liu, Yuyu Zhang, Lingbin Meng, Jinlong Wei, Bin Wang, Huanhuan Wang, Ying Xin, Lihua Dong & Xin Jiang. (2020) Role and toxicity of radiation therapy in neuroblastoma patients: A literature review. Critical Reviews in Oncology/Hematology 149, pages 102924.
Crossref
Crossref
Juntao Bao, Shufeng Zhang, Qinglei Meng & Tao Qin. (2020) SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p. Neurochemical Research 45:4, pages 825-836.
Crossref
Crossref
Eugenio Cavalli, Rosella Ciurleo, Maria Cristina Petralia, Paolo Fagone, Rita Bella, Katia Mangano, Ferdinando Nicoletti, Placido Bramanti & Maria Sofia Basile. (2020) Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?. Molecules 25:5, pages 1194.
Crossref
Crossref
Winifred M Stockton, Theresa Nguyen, Lishi Zhang & Thomas C Dowling. (2019) Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies. Journal of Oncology Pharmacy Practice 26:2, pages 397-405.
Crossref
Crossref
Zekun Yu, Jing Zhang & Jun Han. (2019) Silencing CASC11 curbs neonatal neuroblastoma progression through modulating microRNA-676-3p/nucleolar protein 4 like (NOL4L) axis. Pediatric Research 87:4, pages 662-668.
Crossref
Crossref
Xiaoyan He, Chao Qin, Yanding Zhao, Lin Zou, Hui Zhao & Chao Cheng. (2020) Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma. Cancer Communications 40:2-3, pages 105-118.
Crossref
Crossref
Shengxiang Chen, Wenfeng Tang, Randong Yang, Xiaoxiao Hu & Zhongrong Li. (2020) Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004–2013. The American Surgeon 86:2, pages 127-133.
Crossref
Crossref
Silvia Grasso, Davide Cangelosi, Jennifer Chapelle, Melissa Alzona, Giorgia Centonze, Alessia Lamolinara, Vincenzo Salemme, Costanza Angelini, Alessandro Morellato, Andrea Saglietto, Federico Tommaso Bianchi, Sara Cabodi, Iris Chiara Salaroglio, Federica Fusella, Marzia Ognibene, Manuela Iezzi, Annalisa Pezzolo, Valeria Poli, Ferdinando Di Cunto, Alessandra Eva, Chiara Riganti, Luigi Varesio, Emilia Turco & Paola Defilippi. (2019) The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma. Cell Death & Differentiation 27:2, pages 790-807.
Crossref
Crossref
Hui Zhang, Wenjia Chai, Wei Yang, Wei Han, Wenjun Mou, Yue Xi, Xi Chen, Hui Wang, Wei Wang, Hong Qin, Huanmin Wang, Xiaoli Ma, Xiaolin Wang & Jingang Gui. (2020) The increased IL-17-producing γδT cells promote tumor cell proliferation and migration in neuroblastoma. Clinical Immunology 211, pages 108343.
Crossref
Crossref
A. M. Stroganova, M. V. Rubanskaya, G. Yu. Chemeris, S. L. Dranko, A. I. Karseladze, G. B. Sagoyan & A. P. Kazantsev. (2020) Protein CRABP1 as one of the possible prognosis factors in children with high-risk neuroblastoma. Russian Journal of Pediatric Hematology and Oncology 6:4, pages 48-54.
Crossref
Crossref
L.A. Casulari, D. Dondi, G. Pratesi, F. Piva, M. Milani, M. Piccolella & R. Maggi. (2020) Antiproliferative effect of mifepristone (RU486) on human neuroblastoma cells (SK-N-SH): in vitro and in vivo studies. Brazilian Journal of Medical and Biological Research 53:11.
Crossref
Crossref
Priya Rao, Carmen M. Perrino, Debra L. Zynger, Merce Jorda, Pheroze Tamboli, Diego Fernando Sanchez, Antonio L. Cubilla, Kenneth Iczkowski, Miao Zhang & Kanishka Sircar. 2020. Oncological Surgical Pathology. Oncological Surgical Pathology
1523
1726
.
Srinivas Chava, C. Patrick Reynolds, Anup S. Pathania, Santhi Gorantla, Larisa Y. Poluektova, Don W. Coulter, Subash C. Gupta, Manoj K. Pandey & Kishore B. Challagundla. (2019) miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Molecular Oncology 14:1, pages 180-196.
Crossref
Crossref
Kimberly J. Ornell, Katelyn S. Mistretta, Emily Newman, Coulter Q. Ralston & Jeannine M. Coburn. (2019) Three-Dimensional, Scaffolded Tumor Model to Study Cell-Driven Microenvironment Effects and Therapeutic Responses. ACS Biomaterials Science & Engineering 5:12, pages 6742-6754.
Crossref
Crossref
Jian-Guo Zhou, Bo Liang, Su-Han Jin, Hui-Ling Liao, Guo-Bo Du, Long Cheng, Hu Ma & Udo S. Gaipl. (2019) Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma. Frontiers in Oncology 9.
Crossref
Crossref
Piya Rujkijyanont, Apichat Photia, Chanchai Traivaree, Chalinee Monsereenusorn, Usanarat Anurathapan, Panya Seksarn, Darintr Sosothikul, Piti Techavichit, Kleebsabai Sanpakit, Kamon Phuakpet, Surapon Wiangnon, Thirachit Chotsampancharoen, Su-on Chainansamit, Somjai Kanjanapongkul, Arunotai Meekaewkunchorn & Suradej Hongeng. (2019) Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study. BMC Cancer 19:1.
Crossref
Crossref
Hunter R. Hewitt, Kimberly L. Fugok, Marna Rayl Greenberg, Andrew C. Miller, Mini G. Abraham & Richard J. Mazzaccaro. (2019) Neuroblastoma presenting as hip pain and skull prominence in a child. Radiology Case Reports 14:11, pages 1427-1431.
Crossref
Crossref
Jaques Van Heerden, Marc Hendricks, Jennifer Geel, Benn Sartorius, G. P. Hadley, Jan Du Plessis, Ané Büchner, Gita Naidu, Barry Van Emmenes, Anel Van Zyl & Mariana Kruger. (2019) Overall survival for neuroblastoma in South Africa between 2000 and 2014. Pediatric Blood & Cancer 66:11.
Crossref
Crossref
Displaying 200 of 228 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list